This Logitech International Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Leerink Partners analyst Marc Goodman upgraded the rating for Amylyx Pharmaceuticals, Inc. AMLX from Market Perform to Outperform and raised the price target from $4 to $10. Amylyx Pharmaceuticals shares closed at $4.65 on Tuesday. See how other analysts view this stock.
• Citigroup analyst Geoff Meacham upgraded PTC Therapeutics, Inc. PTCT from Sell to Neutral but lowered the price target from $50 to $40. PTC Therapeutics shares closed at $36.19 on Tuesday. See how other analysts view this stock.
• UBS analyst Joern Iffert upgraded the rating for Logitech International S.A. LOGI from Neutral to Buy. Logitech International shares closed at $76.52 on Tuesday. See how other analysts view this stock.
• Barrington Research analyst James Goss upgraded CuriosityStream Inc. CURI from Market Perform to Outperform and announced a $6 price target. CuriosityStream shares closed at $3.30 on Tuesday. See how other analysts view this stock.

Considering buying LOGI stock? Here’s what analysts think:

Get Started

Earn 7.2% — No Matter What the Fed Does

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds.

Get Started

Read This Next:

• Top 2 Energy Stocks That Are Ticking Portfolio Bombs

Photo via Shutterstock